{"id":177221,"date":"2012-11-19T00:00:00","date_gmt":"2012-11-18T23:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/informations-recentes-novembre-2012\/"},"modified":"2026-04-02T19:11:40","modified_gmt":"2026-04-02T17:11:40","slug":"informations-recentes-novembre-2012","status":"publish","type":"post","link":"https:\/\/h.cbip.be\/fr\/informations-recentes-novembre-2012\/","title":{"rendered":"INFORMATIONS RECENTES NOVEMBRE 2012"},"content":{"rendered":"<div class='tekst'>\n<p> Pour les \u00ab\u00a0Informations R\u00e9centes\u00a0\u00bb de d\u00e9cembre 2012&#x002C; voir la rubrique \u00ab\u00a0Bon \u00e0 savoir\u00a0\u00bb sur notre site Web et les Folia de janvier 2013.<\/p>\n<p> \u00a0<\/p>\n<p> &#8211; Il n\u2019y a pas de nouveaut\u00e9 \u00e0 base de nouveau principe actif.<\/p>\n<p> &#8211; La sp\u00e9cialit\u00e9 <strong>Tetabuline S\/D<\/strong>\u00ae (chapitre 12.2.3.) \u00e0 base d\u2019immunoglobulines antit\u00e9taniques est retir\u00e9e du march\u00e9 pour des raisons commerciales. Les immunoglobulines antit\u00e9taniques sont indiqu\u00e9es en cas de plaies \u00e0 risque de t\u00e9tanos chez les personnes dont l\u2019immunisation est nulle ou douteuse (voir tableau 12b dans le R\u00e9pertoire Comment\u00e9 des M\u00e9dicaments)&#x002C; ainsi que dans le t\u00e9tanos av\u00e9r\u00e9. Des sp\u00e9cialit\u00e9s \u00e0 base d\u2019immunoglobulines antit\u00e9taniques peuvent \u00eatre import\u00e9es de l\u2019\u00e9tranger par le pharmacien sur base d\u2019une d\u00e9claration du m\u00e9decin (via <a href='https:\/\/www.fagg-afmps.be\/fr\/binaries\/AR-KB-2006-12-14-ANNEXE-VI_tcm291-27195.pdf'>www.fagg-afmps.be\/fr\/binaries\/AR-KB-2006-12-14-ANNEXE-VI_tcm291-27195.pdf<\/a>) en respectant la r\u00e9glementation en vigueur (arr\u00eat\u00e9 royal du 14\/12\/2006; article 105). Nous reviendrons sur les modalit\u00e9s de prescription et de d\u00e9livrance de m\u00e9dicaments non disponibles en Belgique dans un prochain num\u00e9ro des Folia.<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pour les \u00ab\u00a0Informations R\u00e9centes\u00a0\u00bb de d\u00e9cembre 2012&#x002C; voir la rubrique  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,181],"tags":[20213,20224],"class_list":["post-177221","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2012-fr","tag-import_tags","tag-import_tags-nl"],"_links":{"self":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=177221"}],"version-history":[{"count":1,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177221\/revisions"}],"predecessor-version":[{"id":179795,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177221\/revisions\/179795"}],"wp:attachment":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=177221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/categories?post=177221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/tags?post=177221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}